U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 020118
Company: BAXTER HLTHCARE
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
SUPRANE DESFLURANE 100% LIQUID;INHALATION Prescription AN Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/18/1992 ORIG-1 Approval Type 1 - New Molecular Entity STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
11/01/2022 SUPPL-26 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020118s026lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/020118Orig1s026ltr.pdf
04/27/2017 SUPPL-24 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020118s024lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020118Orig1s024ltr.pdf
03/01/2019 SUPPL-23 Labeling-Package Insert Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020118s022,s023lbl.pdf
03/01/2019 SUPPL-22 Label (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020118s022,s023lbl.pdf
11/04/2016 SUPPL-21 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020118s021lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020118Orig1s021ltr.pdf
02/26/2015 SUPPL-20 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020118s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020118Orig1s020ltr.pdf
09/27/2013 SUPPL-19 Manufacturing (CMC)

Label is not available on this site.

09/23/2013 SUPPL-18 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020118s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020118Orig1s018ltr.pdf
04/05/2010 SUPPL-17 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020118s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020118s017ltr.pdf
04/14/2009 SUPPL-16 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020118s016lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020118s016ltr.pdf
12/15/2006 SUPPL-12 Efficacy-New Patient Population Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020118s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020118s012ltr.pdf
08/14/2006 SUPPL-11 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020118s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020118s011LTR.pdf
05/08/2006 SUPPL-10 Labeling Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020118s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020118s010ltr.pdf
08/08/2002 SUPPL-8 Manufacturing (CMC)-Packaging Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/20118Orig1s008.pdf
12/02/1999 SUPPL-7 Manufacturing (CMC)-Packaging Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/20118Orig1s007.pdf
12/09/1998 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

12/16/1997 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

07/05/1995 SUPPL-2 Labeling

Label is not available on this site.

03/26/1993 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
11/01/2022 SUPPL-26 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020118s026lbl.pdf
03/01/2019 SUPPL-23 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020118s022,s023lbl.pdf
03/01/2019 SUPPL-22 Manufacturing (CMC) Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020118s022,s023lbl.pdf
04/27/2017 SUPPL-24 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020118s024lbl.pdf
11/04/2016 SUPPL-21 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020118s021lbl.pdf
02/26/2015 SUPPL-20 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020118s020lbl.pdf
09/23/2013 SUPPL-18 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020118s018lbl.pdf
04/05/2010 SUPPL-17 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020118s017lbl.pdf
04/14/2009 SUPPL-16 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020118s016lbl.pdf
12/15/2006 SUPPL-12 Efficacy-New Patient Population Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020118s012lbl.pdf
08/14/2006 SUPPL-11 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020118s011lbl.pdf
05/08/2006 SUPPL-10 Labeling Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020118s010lbl.pdf

SUPRANE

LIQUID;INHALATION; 100%
TE Code = AN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
DESFLURANE DESFLURANE 100% LIQUID;INHALATION Prescription No AN 208234 SHANGHAI HENGRUI
SUPRANE DESFLURANE 100% LIQUID;INHALATION Prescription Yes AN 020118 BAXTER HLTHCARE
Back to Top